Aldeyra Therapeutics
ALDX
ALDX
72 hedge funds and large institutions have $88.9M invested in Aldeyra Therapeutics in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 30 increasing their positions, 19 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
12% less capital invested
Capital invested by funds: $101M → $88.9M (-$12.4M)
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
63% less call options, than puts
Call options by funds: $76K | Put options by funds: $207K
Holders
72
Holding in Top 10
1
Calls
$76K
Puts
$207K
Top Buyers
| 1 | +$1.55M | |
| 2 | +$1.32M | |
| 3 | +$1.18M | |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$487K |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
+$487K |
Top Sellers
| 1 | -$1.95M | |
| 2 | -$1.33M | |
| 3 | -$1.31M | |
| 4 |
Renaissance Technologies
New York
|
-$541K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$377K |